Fluorescent In Situ Hybridization As a Primary Test for HER2 Status in Breast Cancer: Controversies Reply

被引：4
|
作者：
Sauter, Guido [1 ]
Lee, James A. [2 ]
Slamon, Dennis J. [3 ]
Press, Michael F. [4 ,5 ]
机构：
[1] Univ Hamburg, Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany
[2] Altarum Inst, Ann Arbor, MI USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Keck Sch Med, Dept Pathol, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90095 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 05期
关键词：
COST-EFFECTIVENESS ANALYSIS; RECEPTOR; 2; ASSESSMENT; GENE AMPLIFICATION; IMMUNOHISTOCHEMICAL ASSAY; FISH; TRASTUZUMAB; CONCORDANCE; CARCINOMAS; EXPRESSION; HERCEPTEST;
D O I：
10.1200/JCO.2009.25.3930
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E85 / E88
页数：4
相关论文
共 50 条
  • [1] Fluorescent In Situ Hybridization As a Primary Test for HER2 Status in Breast Cancer: Controversies
    Arena, Vincenzo
    Pennacchia, Ilaria
    Monego, Giovanni
    Carbone, Arnaldo
    Capelli, Arnaldo
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) : E83 - E84
  • [2] HER-2 and fluorescent in situ hybridization to evaluate breast cancer - Reply
    Yaziji, H
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (03): : 328 - 329
  • [3] Determination of the HER2 amplification status by in situ fluorescent hybridization and concordance with immunohistochemistry for breast cancer samples in Colombia
    Plata, Adriana
    Torres, Maria Mercedes
    Lopez, Rocio
    Andrade, Rafael E.
    COLOMBIA MEDICA, 2013, 44 (02): : 108 - 114
  • [4] Fluorescent in situ hybridization (FISH) vs immunohistochemistry (IHC) for determination of Her2/neu status in breast cancer.
    Jimenez, RE
    Wallis, T
    Tabaczka, P
    Visscher, DW
    LABORATORY INVESTIGATION, 1999, 79 (01) : 23A - 23A
  • [5] HER2 status in invasive breast cancer: Immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization
    Shirsat, Hemlata S.
    Epari, Sridhar
    Shet, Tanuja
    Bagal, Rajani
    Hawaldar, Rohini
    Desai, Sangeeta B.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (02) : 175 - 179
  • [6] Evaluation of HER2 gene status in breast cancer by chromogenic in situ hybridization:: Comparison with immunohistochemistry
    Kounelis, S
    Kapranos, N
    Malamos, N
    Kouri-Bairaktari, E
    ANTICANCER RESEARCH, 2005, 25 (2A) : 939 - 946
  • [7] Comparison of chromogenic in situ hybridization with other methodologies for HER2 status assesment in breast cancer
    Hauser-Kronberger, C
    Dandachi, N
    JOURNAL OF MOLECULAR HISTOLOGY, 2004, 35 (06) : 647 - 653
  • [8] Comparison of chromogenic in situ hybridization with other methodologies for HER2 status assesment in breast cancer
    Cornelia Hauser-kronberger
    Nadia Dandachi
    Journal of Molecular Histology, 2004, 35 (6) : 647 - 653
  • [9] HER2 in situ hybridization test in breast cancer: quantifying margins of error and genetic heterogeneity
    Polonia, Antonio
    Caramelo, Ana
    MODERN PATHOLOGY, 2021, 34 (08) : 1478 - 1486
  • [10] Correlation of In Situ HER2 RNA Expression With HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Categories in Breast Cancer
    Tseng, Yu-Fen
    Li, Yu-Chia
    Lee, Yi-Hsuan
    Hu, Hsiang-We
    Zhang, Man-San
    Hung, Tze-Chun
    Lien, Huang-Chun
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (03) : e48 - e56
12345